AcuityAds is undervalued ahead of Q2 results, Haywood says

AcuityAds CEO Tal Hayek.
Heading into the company’s second quarter results, Haywood Securities analyst Pardeep Sangha thinks there is money to be made on AcuityAds (TSXV:AT).

On August 14, after market close, AcuityAds will report its Q2, 2018 results. Sangha is modeling an Adjusted EBITDA loss of $200,000 on revenue of $11.5-million, a take that is in-line with the street consensus.

“We believe Acuity is undervalued,” Sangha says. “Acuity’s current share price offers a compelling entry point for investors given the Company has put the bad partners behind it, shored up its balance sheet and is experiencing growth organically and through acquisitions. Acuity is currently trading at 1.1x EV/Revenue of our CY18 estimates, which is lower than its peer group average which trades at 4.3x EV/Revenue of consensus CY18 estimates. Our target price represents 1.1x EV/Revenue multiple and 8.4x EV/EBITDA multiple of our CY19 forecast.”

In a research update to client today, Sangha maintained his “Buy” rating and one-year price target of $1.50 on AT, implying a return of 32.7 per cent at the time of publication.

Sangha thinks AcuityAds will generate Adjusted EBITDA of $2.0-million on revenue of $52.6-million in 2018.

The analyst detailed the key points he will be looking for from the quarter.

“On the conference call, we will be listening for: 1) updated guidance for Q3 and annual revenue growth; 2) improving gross margins and profitability in the second half of CY18; 3) cost synergies from ADman integration and future cross selling opportunities; 4) Update on M&A activity and pipeline,” he said.

Tagged with: at
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Universal Display Corp a buy right now?

In an April 1 report, Roth Capital Markets analyst Scott Searle maintained his “Buy” rating and $180.00 target on Universal… [Read More]

5 days ago

This analyst loves NervGen Pharma

In a March 31 report, Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and US$5.50 target on NervGen… [Read More]

5 days ago

NTG Clarity Networks is a buy, this analyst says

In a March 31 initiation, Ventum Capital Markets analyst Amr Ezzat launched coverage of NTG Clarity Networks (NTG Clarity Networks… [Read More]

6 days ago

Uber is much more than you think, this investor says

In an appearance on BNN Bloomberg Market Call on March 31, Propellus Wealth Partners portfolio manager and senior wealth advisor… [Read More]

6 days ago

Canadian economy is on firmer footing than expected: RBC

In a March 31 report, RBC economist Abbey Xu said the Canadian economy started 2026 on firmer footing than expected,… [Read More]

6 days ago

Should you sell your zSpace stock?

In a March 31 report, Roth Capital Markets analyst Rohit Kulkarni maintained his “Buy” rating on zSpace (zSpace Stock Quote,… [Read More]

6 days ago